This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Kreuter J. Nanoparticles and microparticles for drug and vaccine delivery. J Anat. 1996; 189:503–5.KreuterJNanoparticles and microparticles for drug and vaccine deliveryJ Anat19961895035Search in Google Scholar
Jain N, Jain R, Thakur N, Gupta BP, Jain DK, Banveeri J, Jain S. Nanotechnology: a safe and effective drug delivery system. Asian J Pharm Clin Res. 2010; 3:159–64.JainNJainRThakurNGuptaBPJainDKBanveeriJJainSNanotechnology: a safe and effective drug delivery systemAsian J Pharm Clin Res2010315964Search in Google Scholar
Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther. 2008; 83:761–79.ZhangLGuFXChanJMWangAZLangerRSFarokhzadOCNanoparticles in medicine: therapeutic applications and developmentsClin Pharmacol Ther2008837617910.1038/sj.clpt.610040017957183Search in Google Scholar
Singh S, Kumar V, Pandey, Tewari RP, Agarwal V. Nanoparticle based drug delivery system: advantages and applications. Indian J Sci Technol. 2011; 4:177–80.SinghSKumarVPandeyTewariRPAgarwalVNanoparticle based drug delivery system: advantages and applicationsIndian J Sci Technol201141778010.17485/ijst/2011/v4i3.16Search in Google Scholar
Nikalje AP. Nanotechnology and its applications in medicine. Med Chem. 2015; 5:81–9.NikaljeAPNanotechnology and its applications in medicineMed Chem2015581910.4172/2161-0444.1000247Search in Google Scholar
Weissig V, Pettinger TK, Murdock N. Nanopharmaceuticals (Part 1): products on the market. Int. J. Nanomed. 2014; 9:4357–73.WeissigVPettingerTKMurdockNNanopharmaceuticals (Part 1): products on the marketInt. J. Nanomed2014943577310.2147/IJN.S46900417214625258527Search in Google Scholar
Farjadian F, Ghasemi A, Gohari O, Roointan A, Karimi M, Hamblin MR. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities. Nanomedicine (Lond). 2019; 14:93–126.FarjadianFGhasemiAGohariORoointanAKarimiMHamblinMRNanopharmaceuticals and nanomedicines currently on the market: challenges and opportunitiesNanomedicine (Lond)2019149312610.2217/nnm-2018-0120639163730451076Search in Google Scholar
Hubert V, Chauveau F, Dumot C, Ong E, Berner LP, Canet-Soulas E, et al. Clinical imaging of choroid plexus in health and in brain disorders: a mini-review. Front Mol Neurosci. 2019; 12:34.HubertVChauveauFDumotCOngEBernerLPCanet-SoulasEClinical imaging of choroid plexus in health and in brain disorders: a mini-reviewFront Mol Neurosci2019123410.3389/fnmol.2019.00034637945930809124Search in Google Scholar
Guo B, Wen B, Cheng W, Zhou X, Duan X, Zhao M, et al. An enzyme-free and label-free surface plasmon resonance biosensor for ultrasensitive detection of fusion gene based on DNA self-assembly hydrogel with streptavidin encapsulation. Biosens Bioelectron. 2018; 112:120–6.GuoBWenBChengWZhouXDuanXZhaoMAn enzyme-free and label-free surface plasmon resonance biosensor for ultrasensitive detection of fusion gene based on DNA self-assembly hydrogel with streptavidin encapsulationBiosens Bioelectron2018112120610.1016/j.bios.2018.04.02729702383Search in Google Scholar
Gwinn MR, Vallyathan V. Nanoparticles: health effects – pros and cons. Environ Health Perspect. 2006; 114:1818–25.GwinnMRVallyathanVNanoparticles: health effects – pros and consEnviron Health Perspect200611418182510.1289/ehp.8871176416117185269Search in Google Scholar
Prabha S, Labhasetwar V. Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells. Mol Pharm. 2004; 1:211–9.PrabhaSLabhasetwarVNanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cellsMol Pharm20041211910.1021/mp049970+15981924Search in Google Scholar
Kelly HG, Kent SJ, Wheatley AK. Immunological basis for enhanced immunity of nanoparticle vaccines. Expert Rev Vaccines. 2019; 18:269–80.KellyHGKentSJWheatleyAKImmunological basis for enhanced immunity of nanoparticle vaccinesExpert Rev Vaccines2019182698010.1080/14760584.2019.157821630707635Search in Google Scholar
Kowalski PS, Rudra A, Miao L, Anderson DG. Delivering the messenger: advances in technologies for therapeutic mRNA delivery. Mol Ther. 2019; 27:710–28.KowalskiPSRudraAMiaoLAndersonDGDelivering the messenger: advances in technologies for therapeutic mRNA deliveryMol Ther2019277102810.1016/j.ymthe.2019.02.012645354830846391Search in Google Scholar
Bawa R, Bawa SR, Meibius SB. Protecting new ideas and invention in nanomedicine with patent. Nanomedicine. 2005; 1:150–8.BawaRBawaSRMeibiusSBProtecting new ideas and invention in nanomedicine with patentNanomedicine20051150810.1016/j.nano.2005.03.00917292072Search in Google Scholar
Wadher K, Kalsait R, Umekar M. Alternate drug delivery system: recent advancement and future challenges. Arch Pharm Sci Res. 2009; 1:97–105.WadherKKalsaitRUmekarMAlternate drug delivery system: recent advancement and future challengesArch Pharm Sci Res2009197105Search in Google Scholar
Siemer S, Westmeier D, Barz M, Eckrich J, Wünsch D, Seckert C, et al. Biomolecule-corona formation confers resistance of bacteria to nanoparticle-induced killing: implications for the design of improved nanoantibiotics. Biomaterials. 2019; 192:551–9.SiemerSWestmeierDBarzMEckrichJWünschDSeckertCBiomolecule-corona formation confers resistance of bacteria to nanoparticle-induced killing: implications for the design of improved nanoantibioticsBiomaterials2019192551910.1016/j.biomaterials.2018.11.02830530244Search in Google Scholar
Buch PJ, Chai Y, Goluch ED. Treating polymicrobial infections in chronic diabetic wounds. Clin Microbiol Rev. 2019; 32. pii: e00091–18.BuchPJChaiYGoluchEDTreating polymicrobial infections in chronic diabetic woundsClin Microbiol Rev201932pii:e000911810.1128/CMR.00091-18643112930651226Search in Google Scholar
Shaikh AJ, Aman N, Yameen MA. A new methodology for simultaneous comparison and optimization between nanoparticles and their drug conjugates against various multi drug resistant bacteria. Asian Biomed (Res Rev News). 2019; 13:149–162.ShaikhAJAmanNYameenMAA new methodology for simultaneous comparison and optimization between nanoparticles and their drug conjugates against various multi drug resistant bacteriaAsian Biomed (Res Rev News)20191314916210.1515/abm-2019-0054Search in Google Scholar
